BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 3 for the treatment of life-threatening complications of liver...
17 insider purchases on record · latest filing 2026-08-28.
Insiders have also filed 8 sale transactions at BIVI.